Annual Shareholders Equity
-$4.71 M
+$3.34 M+41.48%
December 31, 2023
Summary
- As of February 7, 2025, PBLA annual stockholders equity is -$4.71 million, with the most recent change of +$3.34 million (+41.48%) on December 31, 2023.
- During the last 3 years, PBLA annual shareholders equity has fallen by -$13.16 million (-155.75%).
- PBLA annual shareholders equity is now -146.12% below its all-time high of $10.21 million, reached on December 31, 2021.
Performance
PBLA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$18.17 M
-$7.60 M-71.92%
September 30, 2024
Summary
- As of February 7, 2025, PBLA quarterly stockholders equity is -$18.17 million, with the most recent change of -$7.60 million (-71.92%) on September 30, 2024.
- Over the past year, PBLA quarterly shareholders equity has dropped by -$13.46 million (-285.73%).
- PBLA quarterly shareholders equity is now -234.95% below its all-time high of $13.46 million, reached on September 30, 2021.
Performance
PBLA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
PBLA Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +41.5% | -285.7% |
| 3 y3 years | -155.8% | -816.7% |
| 5 y5 years | -1857.5% | -816.7% |
PBLA Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -146.1% | +41.5% | -277.9% | at low |
| 5 y | 5-year | -146.1% | +41.5% | -234.9% | at low |
| alltime | all time | -146.1% | +41.5% | -234.9% | at low |
Panbela Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$18.17 M(+71.9%) |
| Jun 2024 | - | -$10.57 M(+231.7%) |
| Mar 2024 | - | -$3.19 M(-32.4%) |
| Dec 2023 | -$4.71 M(-41.5%) | -$4.71 M(+89.7%) |
| Sep 2023 | - | -$2.48 M(-151.7%) |
| Jun 2023 | - | $4.80 M(+89.4%) |
| Mar 2023 | - | $2.54 M(-131.5%) |
| Dec 2022 | -$8.05 M(-178.8%) | -$8.05 M(-2.8%) |
| Sep 2022 | - | -$8.28 M(+71.1%) |
| Jun 2022 | - | -$4.84 M(-173.5%) |
| Mar 2022 | - | $6.58 M(-35.6%) |
| Dec 2021 | $10.21 M(+20.9%) | $10.21 M(-24.1%) |
| Sep 2021 | - | $13.46 M(+128.1%) |
| Jun 2021 | - | $5.90 M(-22.2%) |
| Mar 2021 | - | $7.58 M(-10.2%) |
| Dec 2020 | $8.45 M(+510.0%) | $8.45 M(-11.5%) |
| Sep 2020 | - | $9.55 M(+496.8%) |
| Jun 2020 | - | $1.60 M(+121.0%) |
| Mar 2020 | - | $724.00 K(-47.7%) |
| Dec 2019 | $1.39 M(+416.8%) | $1.39 M(-42.0%) |
| Sep 2019 | - | $2.39 M(-2141.9%) |
| Jun 2019 | - | -$117.00 K(-80.1%) |
| Mar 2019 | - | -$588.00 K(-319.4%) |
| Dec 2018 | $268.00 K | $268.00 K(-149.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | -$542.00 K(-592.7%) |
| Jun 2018 | - | $110.00 K(-104.7%) |
| Mar 2018 | - | -$2.32 M(-37.1%) |
| Dec 2017 | -$3.69 M(-20.5%) | -$3.69 M(+75.8%) |
| Sep 2017 | - | -$2.10 M(+119.8%) |
| Jun 2017 | - | -$955.00 K(-382.5%) |
| Mar 2017 | - | $338.00 K(-107.3%) |
| Dec 2016 | -$4.64 M(+73.1%) | -$4.64 M(+32.4%) |
| Sep 2016 | - | -$3.50 M(+32.8%) |
| Jun 2016 | - | -$2.64 M(-24.7%) |
| Mar 2016 | - | -$3.50 M(+30.7%) |
| Dec 2015 | -$2.68 M(+103.7%) | -$2.68 M(+34.8%) |
| Sep 2015 | - | -$1.99 M(+434.5%) |
| Jun 2015 | - | -$372.10 K(+28.2%) |
| Mar 2015 | - | -$290.30 K(-77.9%) |
| Dec 2014 | -$1.32 M(+854.3%) | -$1.32 M(+250.0%) |
| Sep 2014 | - | -$376.00 K(+30.2%) |
| Jun 2014 | - | -$288.80 K(+20.3%) |
| Mar 2014 | - | -$240.00 K(+74.0%) |
| Dec 2013 | -$137.90 K(+238.0%) | -$137.90 K(+8.8%) |
| Sep 2013 | - | -$126.70 K(+38.8%) |
| Jun 2013 | - | -$91.30 K(+6.0%) |
| Mar 2013 | - | -$86.10 K(+111.0%) |
| Dec 2012 | -$40.80 K(-89.9%) | -$40.80 K |
| Dec 2011 | -$405.00 K | - |
FAQ
- What is Panbela Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Panbela Therapeutics?
- What is Panbela Therapeutics annual shareholders equity year-on-year change?
- What is Panbela Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Panbela Therapeutics?
- What is Panbela Therapeutics quarterly shareholders equity year-on-year change?
What is Panbela Therapeutics annual stockholders equity?
The current annual shareholders equity of PBLA is -$4.71 M
What is the all time high annual shareholders equity for Panbela Therapeutics?
Panbela Therapeutics all-time high annual stockholders equity is $10.21 M
What is Panbela Therapeutics annual shareholders equity year-on-year change?
Over the past year, PBLA annual stockholders equity has changed by +$3.34 M (+41.48%)
What is Panbela Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of PBLA is -$18.17 M
What is the all time high quarterly shareholders equity for Panbela Therapeutics?
Panbela Therapeutics all-time high quarterly stockholders equity is $13.46 M
What is Panbela Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, PBLA quarterly stockholders equity has changed by -$13.46 M (-285.73%)